Literature DB >> 23385439

Prognosis in the era of comparative effectiveness research.

Mario Petretta, Alberto Cuocolo.   

Abstract

Mesh：

Year:  2013        PMID： 23385439     DOI： 10.1007/s12350-013-9682-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

1.  Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Olga V Demler
Journal:  Stat Med       Date:  2011-12-07       Impact factor: 2.373

Review 2.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

3.  Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Peter W F Wilson; Rory Hachamovitch; Robert C Hendel; Salvador Borges-Neto; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2010-11

4.  Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ewout W Steyerberg
Journal:  Stat Med       Date:  2010-11-05       Impact factor: 2.373
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.